Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111394 · ClinicalTrials.gov registry record
Study of myMS in Participants With a Diagnosis of Multiple Sclerosis
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 200
- Enrollment target
NCT03111394: Completed study, sponsored by University of Southern California.
NCT03111394 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03111394 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This is a pilot study looking at the feasibility of a mobile application (app) to collect data from active tasks (questionnaires, 6Mapp™, COGapp™, VISapp™), clinical magnetic resonance imaging information and conduct genome-wide association studies in subjects with multiple sclerosis. Participants will be self-referred to this study from different sources; patient advocacy groups, social media tools, clinicaltrials.gov, and flyers.
Primary Outcome
Proportion of participants with both genetic and MRI data available
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2021-11-25 |
What the finished NCT03111394 record still lists
NCT03111394 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03111394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03111394 about?
NCT03111394 is a clinical study titled "Study of myMS in Participants With a Diagnosis of Multiple Sclerosis". This is a pilot study looking at the feasibility of a mobile application (app) to collect data from active tasks (questionnaires, 6Mapp™, COGapp™, VISapp™), clinical magnetic resonance imaging information and conduct genome-wide association studies in subjects with multiple sclerosis. Participants w...
What is the current status of trial NCT03111394?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2017-04-17. Estimated completion is 2021-11-25.
Who is sponsoring clinical trial NCT03111394?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI